(FM) Oncología

2020

1. A Trial of Lopinavir-Ritonavir in Covid-19

   The New England journal of medicine

2. Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?

   Journal of Thoracic Oncology

3. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers

   International Journal of Gynecological Cancer

4. COVID-19 Global Pandemic: Options for Management of Gynecologic Cancers

   Obstetrical and Gynecological Survey

5. Does active smoking worsen Covid-19?

   European Journal of Internal Medicine

6. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

   Radiotherapy and Oncology

7. Management plan for breast cancer during the COVID-19 pandemic. A single-institution alternative to treat early breast cancer patients in a short time

   Breast Journal

8. Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

   Obstetrical and Gynecological Survey

9. PARP Inhibitors in Ovarian Cancer. Reply

   The New England journal of medicine

10. PARP inhibitors in ovarian cancer

    New England Journal of Medicine

11. Realización de pruebas innecesarias en los ensayos clínicos: HCG como ejemplo

    Advances in Laboratory Medicine

12. Single-Institution Experience in Clinical Trials during the COVID-19 Pandemic in Spain: Not So Bad after All?

    JCO Global Oncology

13. Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels

    Journal of Investigational Allergology and Clinical Immunology

14. Unnecessary test ordering in clinical trials: Human chorionic gonadotropin as an example

    Advances in Laboratory Medicine

15. interprofessional education: A proposal from the University of Navarra

    Educacion Medica